WAVE Life Sciences

$4.34 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About WAVE Life Sciences

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.

Stock Analysis

last close $4.34
1-mo return -25.8%
3-mo return -32.8%
avg daily vol. 383.03T
52-week high 12.17
52-week low 4.16
market cap. $261M
forward pe -
annual div. -
roe -1650%
ltg forecast -
dividend yield -
annual rev. $16M
inst own. 73.7%

Subscribe now for daily local and international financial news